How Did You Design This Study?

This is a study that we actually arose from friendship, to be honest, and from clinical interest. We started using thrombotic therapy in patients on dogs already some years ago. And then we were actually interested to see whether this is a systematic question, which also others are pursuing. So our main question was about the bleeding risk, the risk of symptomatic intratrenal bleeding after thrombolytic therapy.